Search results
Results from the WOW.Com Content Network
The first human cases of COVID-19 occurred in Wuhan, People's Republic of China, on or about 17 November 2019. [2] The first confirmed human case in the United States was on 19 January 2020. The World Health Organization declared the COVID-19 outbreak a Public Health Emergency of International Concern (PHEIC) on 30 January 2020, and first ...
The development of COVID-19 tests was a major public health priority during the early months of the COVID-19 pandemic. In January 2020, scientists from China published the first genetic sequences of SARS-CoV-2 via virological.org , [ 3 ] a "hub for prepublication data designed to assist with public health activities and research". [ 4 ]
All RMPs for COVID‑19 vaccines will be published on the EMA's website. [136] The EMA published guidance for developers of potential COVID‑19 vaccines on the clinical evidence to include in marketing authorization applications. [137] In November 2020, the CHMP started a rolling review of the Moderna vaccine for COVID‑19 known as mRNA-1273 ...
The species was merged with Rat coronavirus (discovered in 1970 [23]) and Puffinosis coronavirus (discovered in 1982 [59]) as Murine coronavirus in 2009. [60] 229E and OC43 were collectively named Human respiratory virus but merged as Human coronavirus 229E (HCoV-229E) in 2009. [61]
This article documents the chronology and epidemiology of SARS-CoV-2 in 2019, the virus that causes coronavirus disease 2019 and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 known to have been identified were in Wuhan , Hubei , China , in December 2019.
The world's first COVID-19 drug designed by generative AI is approved for human use, with clinical trials expected to begin in China. The new drug, ISM3312, is developed by Insilico Medicine. [389] A new AI algorithm developed by Baidu is shown to boost the antibody response of COVID-19 mRNA vaccines by 128 times. [390]
The COVID-19 pandemic (also known as the coronavirus pandemic and COVID pandemic), caused by severe acute respiratory syndrome coronavirus 2 , began with an outbreak of COVID-19 in Wuhan, China, in December 2019.
The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]